Skip to main content

Peak Pharmaceuticals Stock Forecast, Price & News

0.00 (-0.18 %)
(As of 05/14/2021 03:53 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume33,359 shs
Average Volume363,646 shs
Market Capitalization$8.60 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive PKPH News and Ratings via Email

Sign-up to receive the latest news and ratings for Peak Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Peak Pharmaceuticals logo

About Peak Pharmaceuticals

Peak Pharmaceuticals, Inc. operates as a bio­pharmaceutical and nutraceutical company in the United States. The company focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. It is involved in the development of over-the-counter, THC­free, hemp based products for human market for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc. in December 2014. Peak Pharmaceuticals, Inc. was incorporated in 2007 and is based in Scottsdale, Arizona.


See More Headlines

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:PKPH
Year FoundedN/A

Sales & Book Value

Annual SalesN/A





Market Cap$8.60 million
Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.74 out of 5 stars

Medical Sector

1263rd out of 2,039 stocks

Pharmaceutical Preparations Industry

549th out of 769 stocks

Analyst Opinion: 0.0Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Peak Pharmaceuticals (OTCMKTS:PKPH) Frequently Asked Questions

What stocks does MarketBeat like better than Peak Pharmaceuticals?

Wall Street analysts have given Peak Pharmaceuticals a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Peak Pharmaceuticals wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Peak Pharmaceuticals' stock been impacted by Coronavirus?

Peak Pharmaceuticals' stock was trading at $0.0176 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PKPH shares have increased by 523.9% and is now trading at $0.1098.
View which stocks have been most impacted by COVID-19

Who are Peak Pharmaceuticals' key executives?

Peak Pharmaceuticals' management team includes the following people:
  • Mr. Neil T. Reithinger, CEO, Pres, CFO, Principal Accounting Officer, Treasurer, Sec. & Director (Age 51)

Who are some of Peak Pharmaceuticals' key competitors?

What other stocks do shareholders of Peak Pharmaceuticals own?

What is Peak Pharmaceuticals' stock symbol?

Peak Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PKPH."

How do I buy shares of Peak Pharmaceuticals?

Shares of PKPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Peak Pharmaceuticals' stock price today?

One share of PKPH stock can currently be purchased for approximately $0.11.

How much money does Peak Pharmaceuticals make?

Peak Pharmaceuticals has a market capitalization of $8.60 million.

How many employees does Peak Pharmaceuticals have?

Peak Pharmaceuticals employs 1 workers across the globe.

What is Peak Pharmaceuticals' official website?

The official website for Peak Pharmaceuticals is

Where are Peak Pharmaceuticals' headquarters?

Peak Pharmaceuticals is headquartered at 14201 N. HAYDEN ROAD SUITE A-1, SCOTTSDALE AZ, 85260.

How can I contact Peak Pharmaceuticals?

Peak Pharmaceuticals' mailing address is 14201 N. HAYDEN ROAD SUITE A-1, SCOTTSDALE AZ, 85260. The company can be reached via phone at 480-659-6404 or via email at [email protected]

This page was last updated on 5/15/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.